These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 955238)

  • 1. Bioavailability of topical steroids.
    Barry BW
    Dermatologica; 1976; 152 Suppl 1():47-65. PubMed ID: 955238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability and activity of topical corticosteroids from a novel drug delivery system, the aerosol quick-break foam.
    Woodford R; Barry BW
    J Pharm Sci; 1977 Jan; 66(1):99-103. PubMed ID: 319219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative bio-availability of proprietary topical corticosteroid preparations; vasoconstrictor assays on thirty creams and gels.
    Barry BW; Woodford R
    Br J Dermatol; 1974 Sep; 91(3):323-38. PubMed ID: 4611447
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioavailability and activity of betamethasone 17-benzoate in gel and cream formulations: comparison with proprietary topical corticosteroid preparations in the vasoconstrictor assay.
    Woodford R; Barry BW
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):338-45. PubMed ID: 4208350
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of activity of different topical corticosteroid creams and ointments using a vasoconstriction assay: superiority of hydrocortisone butyrate over hydrocortisone].
    Korting HC; Maslen K; Gross G; Willers C
    J Dtsch Dermatol Ges; 2005 May; 3(5):348-53. PubMed ID: 16372801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of measuring the bioavailability of topical betamethasone dipropionate in commercial formulations using drug content in skin and a skin blanching bioassay.
    Pershing LK; Silver BS; Krueger GG; Shah VP; Skelley JP
    Pharm Res; 1992 Jan; 9(1):45-51. PubMed ID: 1589409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetration of topical corticosteroids through human epidermis.
    Osamura H
    J Dermatol; 1982 Feb; 9(1):45-58. PubMed ID: 7047607
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: Topical availability of hydrocortisone from different ointment bases.
    Ritschel WA; Kitzmiller KW; Serracino-Inglott A
    Rev Can Biol; 1973; 32():Suppl:91-7. PubMed ID: 4777607
    [No Abstract]   [Full Text] [Related]  

  • 9. Objective determination of the bioavailability of dermocorticoids--influence of the formulation.
    Poelman MC; Leveque JL; Le Gall F
    Br J Dermatol; 1984 Jul; 111 Suppl 27():158-62. PubMed ID: 6743548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of different desoximetasone preparations compared to other topical corticosteroids in the vasoconstriction assay.
    Borelli C; Gassmueller J; Fluhr JW; Nietsch KH; Schinzel S; Korting HC
    Skin Pharmacol Physiol; 2008; 21(3):181-7. PubMed ID: 18523415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Objective measurement of topically applied corticosteroids.
    Király K; Soós G
    Dermatologica; 1976; 152 Suppl 1():133-7. PubMed ID: 955233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of bioavailability of topical steroids: non-occluded penetration enhancers under thermodynamic control.
    Bennett SL; Barry BW; Woodford R
    J Pharm Pharmacol; 1985 May; 37(5):298-304. PubMed ID: 2862236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The absorption of topical corticosteroids, with particular reference to percutaneous absorption in infancy and childhood.
    Keipert JA
    Med J Aust; 1971 May; 1(19):1021-5. PubMed ID: 4930660
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessing equivalence of innovator and generic formulations of betamethasone dipropionate cream and ointment.
    Sequira J; Berardi M; Chan TM; Letarte J; Malchow R; Pramanick B; Wolkoff HN
    Clin Ther; 1991; 13(6):687-94. PubMed ID: 1790543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration of corticosteroids through the skin in relation to the vehicle.
    Ponec M
    Dermatologica; 1976; 152 Suppl 1():37-46. PubMed ID: 955237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proprietary hydrocortisone creams. Vasoconstrictor activities and bio-availabilities of six preparations.
    Barry BW; Woodford R
    Br J Dermatol; 1976 Oct; 95(4):423-5. PubMed ID: 974028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration of various corticosteroids through epidermis in vitro.
    Ponec M; Polano MK
    Arch Dermatol Res; 1979 May; 265(1):101-4. PubMed ID: 475440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vehicle design for a new topical steroid, fluocinonide.
    Ostrenga J; Haleblian J; Poulsen B; Ferrell B; Mueller N; Shastri S
    J Invest Dermatol; 1971 May; 56(5):392-9. PubMed ID: 5556528
    [No Abstract]   [Full Text] [Related]  

  • 19. Potency ranking of two new topical corticosteroid creams containing 0.1% desonide or 0.05% halometasone utilising the human skin blanching assay.
    Meyer E; Smith EW; Haigh JM; Kanfer I
    Arzneimittelforschung; 1988 Dec; 38(12):1840-3. PubMed ID: 3245859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onset of the vasoconstrictor effect of diflucortolone valerate, betamethasone valerate, and fluocinolone acetonide ointments applied for varying periods under occlusive dressings.
    Szadurski J; Renz F; Gasser D
    Dermatologica; 1976; 153(4):236-42. PubMed ID: 1017533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.